1-3 of 3
Hideaki Miyake
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma

Open Access
Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, Ryuji Matsumoto, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (4): 532–540.
https://doi.org/10.1158/1535-7163.MCT-23-0187
Published: 02 April 2024
View articletitled, TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
Open the PDF for TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma in another window
Includes: Supplementary data
Journal Articles

A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells

Free
Kazuki Yamanaka, Palma Rocchi, Hideaki Miyake, Ladan Fazli, Bob Vessella, Uwe Zangemeister-Wittke, Martin E. Gleave
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (11): 1689–1698.
https://doi.org/10.1158/1535-7163.MCT-05-0064
Published: 07 November 2005
View articletitled, A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells
Open the PDF for A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells in another window
Journal Articles

Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model

Free
Kazuki Yamanaka, Martin E. Gleave, Isao Hara, Mototsugu Muramaki, Hideaki Miyake
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (2): 187–195.
https://doi.org/10.1158/1535-7163.187.4.2
Published: 15 February 2005
View articletitled, Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model
Open the PDF for Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model in another window